Likewise, the risk of PD,77 hepatic steatosis,78 and coronary artery disease79 seems to be increased in individuals with the ALDH2*2 polymorphism, which is also confirmed by large‐scale meta‐analysis for risk assessment to develop essential hypertension.80 This evidence concerns the gene ALDH2 and essential hypertension.